Transdermal testosterone gel for poor ovarian responders. A multicenter double-blind placebo controlled randomized trial.

Trial Profile

Transdermal testosterone gel for poor ovarian responders. A multicenter double-blind placebo controlled randomized trial.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 22 Dec 2016

At a glance

  • Drugs Testosterone (Primary)
  • Indications Female infertility
  • Focus Therapeutic Use
  • Acronyms T-TRANSPORT
  • Most Recent Events

    • 19 Dec 2016 Planned End Date changed from 11 Aug 2017 to 1 Dec 2017.
    • 21 Aug 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top